These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291 [TBL] [Abstract][Full Text] [Related]
25. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry. Gondolesi GE; Pape UF; Mason JB; Allard JP; Pironi L; Casas MNV; Schwartz LK; Joly F; Gabriel A; Sabrdaran S; Zhang P; Kohl-Sobania M; Huang YW; Jeppesen PB Nutrients; 2024 Aug; 16(15):. PubMed ID: 39125394 [TBL] [Abstract][Full Text] [Related]
26. Gut hormones in the treatment of short-bowel syndrome and intestinal failure. Jeppesen PB Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):14-20. PubMed ID: 25485516 [TBL] [Abstract][Full Text] [Related]
28. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials. Seidner DL; Gabe SM; Lee HM; Olivier C; Jeppesen PB JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614 [TBL] [Abstract][Full Text] [Related]
29. Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects. Vipperla K; O'Keefe SJ Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):683-7. PubMed ID: 24134154 [TBL] [Abstract][Full Text] [Related]
30. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study. Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915 [TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure. O'Keefe SJ; Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B Clin Gastroenterol Hepatol; 2013 Jul; 11(7):815-23.e1-3. PubMed ID: 23333663 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support. Chiba M; Masumoto K; Kaji T; Matsuura T; Morii M; Fagbemi A; Hill S; Pakarinen MP; Protheroe S; Urs A; Chen ST; Sakui S; Udagawa E; Wada M J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):339-346. PubMed ID: 37364133 [TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome. Marier JF; Jomphe C; Peyret T; Wang Y Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. Hargrove DM; Alagarsamy S; Croston G; Laporte R; Qi S; Srinivasan K; Sueiras-Diaz J; Wiśniewski K; Hartwig J; Lu M; Posch AP; Wiśniewska H; Schteingart CD; Rivière PJ; Dimitriadou V J Pharmacol Exp Ther; 2020 May; 373(2):193-203. PubMed ID: 32075870 [TBL] [Abstract][Full Text] [Related]
35. Teduglutide in short bowel syndrome patients: A way back to normal life? Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239 [TBL] [Abstract][Full Text] [Related]
36. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome. Tappenden KA; Edelman J; Joelsson B J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461 [TBL] [Abstract][Full Text] [Related]
37. Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series. Armstrong D; Forbes A; Jeppesen PB; Lee HM; Nagy P; Seidner DL Clin Nutr; 2020 Jun; 39(6):1774-1777. PubMed ID: 31522784 [TBL] [Abstract][Full Text] [Related]
38. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data. Ramos Boluda E; Redecillas Ferreiro S; Manrique Moral O; García Romero R; Irastorza Terradillos I; Nuñez Ramos R; Germán Díaz M; Polo Miquel B; Vives Piñera I; Alcolea Sánchez A; González Sacristán R; Bautista Barea M; Moreno Villares JM J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):734-739. PubMed ID: 32804906 [TBL] [Abstract][Full Text] [Related]
39. Teduglutide in intestinal adaptation and repair: light at the end of the tunnel. Mardini HE; de Villiers WJ Expert Opin Investig Drugs; 2008 Jun; 17(6):945-51. PubMed ID: 18491995 [TBL] [Abstract][Full Text] [Related]
40. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome. Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]